Efficacy of denosumab for restoring normal bone mineral density in women receiving adjuvant aromatase inhibitors for early breast cancer

BACKGROUND: Osteoporosis is a major side effect of aromatase inhibitors (AIs), which are greatly effective in the treatment of breast cancer. However, there are no satisfactory measures against osteoporosis. In this multicenter, randomized, comparative study, we evaluate the efficacy of denosumab fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakaguchi, Koichi, Ono, Hisako, Nakatsukasa, Katsuhiko, Ishikawa, Takashi, Hasegawa, Yoshie, Takahashi, Masato, Niikura, Naoki, Koizumi, Kei, Sakurai, Teruhisa, Shigematsu, Hideo, Takahashi, Shunji, Taira, Shinichiro, Suzuki, Masato, Narui, Kazutaka, Miura, Daishu, Yamada, Kimito, Yoshimura, Mana, Shioya, Hisashi, Konishi, Eiichi, Isao, Yokota, Imai, Kojiro, Fujikawa, Kei, Taguchi, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708609/
https://www.ncbi.nlm.nih.gov/pubmed/31393399
http://dx.doi.org/10.1097/MD.0000000000016770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708609/
https://www.ncbi.nlm.nih.gov/pubmed/31393399
http://dx.doi.org/10.1097/MD.0000000000016770

Ejemplares similares